Phase 1 Study to Assess the Effects of EVP-6124 on the QT/QTc Interval in Healthy Subjects

Clinical trial NCT01487135 · COMPLETED

Trial details

NCT number: NCT01487135
Sponsor: FORUM Pharmaceuticals Inc
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Subjects Cardiac Repolarization

Start date: 2011-12-01
Primary completion: 2013-09-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.